His motives.

If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.

Who would have guessed? Well, just about anyone not deeply deluded by Trump’s claims to put America first.

via Surprise! Donald Trump Has A Financial Stake In Hydroxychloroquine | Crooks and Liars